Literature DB >> 19252016

Azithromycin therapy for neutrophilic airways disease: myth or magic?

Saad F Idris, Edwin R Chilvers, Charles Haworth, Damian McKeon, Alison M Condliffe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19252016     DOI： 10.1136/thx.2008.103192

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  8 in total

Review 1.  Cytokine and anti-cytokine therapy in asthma: ready for the clinic?

Authors:  D Desai; C Brightling
Journal:  Clin Exp Immunol       Date:  2009-10       Impact factor: 4.330

2.  Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection.

Authors:  Maurizio Renna; Catherine Schaffner; Karen Brown; Shaobin Shang; Marcela Henao Tamayo; Krisztina Hegyi; Neil J Grimsey; David Cusens; Sarah Coulter; Jason Cooper; Anne R Bowden; Sandra M Newton; Beate Kampmann; Jennifer Helm; Andrew Jones; Charles S Haworth; Randall J Basaraba; Mary Ann DeGroote; Diane J Ordway; David C Rubinsztein; R Andres Floto
Journal:  J Clin Invest       Date:  2011-08-01       Impact factor: 14.808

Review 3.  Autophagy in Pulmonary Diseases.

Authors:  Kiichi Nakahira; Maria Angelica Pabon Porras; Augustine M K Choi
Journal:  Am J Respir Crit Care Med       Date:  2016-11-15       Impact factor: 21.405

4.  Azithromycin and ciprofloxacin inhibit interleukin-8 secretion without disrupting human sinonasal epithelial integrity in vitro.

Authors:  Dong-Jin Lim; Harrison M Thompson; Christopher R Walz; Samrath Ayinala; Daniel Skinner; Shaoyan Zhang; Jessica W Grayson; Do-Yeon Cho; Bradford A Woodworth
Journal:  Int Forum Allergy Rhinol       Date:  2020-07-28       Impact factor: 3.858

5.  AZTEC-azithromycin therapy for prevention of chronic lung disease of prematurity: a statistical analysis plan for clinical outcomes.

Authors:  Tin Man Mandy Lau; John Lowe; Timothy Pickles; Kerenza Hood; Sailesh Kotecha; David Gillespie
Journal:  Trials       Date:  2022-08-23       Impact factor: 2.728

6.  Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls [corrected].

Authors:  Kristina Krempaska; Sandra Barnowski; Jacopo Gavini; Nina Hobi; Simone Ebener; Cedric Simillion; Andrea Stokes; Ronja Schliep; Lars Knudsen; Thomas K Geiser; Manuela Funke-Chambour
Journal:  Respir Res       Date:  2020-01-15

Review 7.  Preventing the development of severe COVID-19 by modifying immunothrombosis.

Authors:  Gerwyn Morris; Chiara C Bortolasci; Basant K Puri; Lisa Olive; Wolfgang Marx; Adrienne O'Neil; Eugene Athan; Andre Carvalho; Michael Maes; Ken Walder; Michael Berk
Journal:  Life Sci       Date:  2020-10-20       Impact factor: 5.037

Review 8.  Can endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19?

Authors:  Gerwyn Morris; Eugene Athan; Ken Walder; Chiara C Bortolasci; Adrienne O'Neil; Wolf Marx; Michael Berk; André F Carvalho; Michael Maes; Basant K Puri
Journal:  Life Sci       Date:  2020-10-06       Impact factor: 6.780
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.